Submitting priority documents for industrial design applications in Canada has just become more efficient! On April 1, 2019, the Canadian Intellectual Property Office (CIPO) continued the modernization of Canada’s industrial design regime by joining the World Intellectual Property Organization’s Digital Access Service (DAS) for industrial design applications. The use of the DAS eliminates the cost of obtaining certified copies of priority documents for submission in participating jurisdictions.
Now that the CIPO has joined the DAS, an applicant with a priority claim in a participating jurisdiction, such as the US, China and the Republic of Korea, may submit a priority document simply by providing the CIPO with the number and filing date of the priority application, as well as the access code required to retrieve the priority document from the DAS. Conversely, applicants who first file in Canada will be able to request that their Canadian application be made available on the DAS.
While applicants are not required to submit priority documents to support a priority claim for Canadian industrial design applications unless specifically requisitioned by an Examiner, promptly submitting a certified copy of the priority document may provide the benefit of accelerating examination by up to six months. The extent to which examination is accelerated will depend on the back log of applications on file at the Industrial Design Office. If the priority document is not in English or French, a translation into either English or French will also be required to realize the benefit of filing the priority document. The translation may be submitted by letter.
Although the new service is currently available only for industrial design applications, the CIPO has indicated that it intends to expand the service to patent applications when Canada accedes to the Patent Law Treaty.
For further details concerning updates to Canada’s industrial design regime, please contact any member of our Industrial Designs Group.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
Related Publications & Articles
-
Supreme Court of Canada: methods of medical treatment unpatentable, validity of Janssen’s paliperidone dosing regimen patent upheld
Today the Supreme Court of Canada released its decision in Pharmascience Inc v Janssen Inc, 2026 SCC 26 on the patentability of methods of medical treatment, dismissing Pharmascience’s appeal.Read More -
New USPTO rules will affect Canadian innovators not represented by a patent attorney or patent agent
Foreign filing licenses are a common but often overlooked requirement that can create headaches for patent applicants. Failure to obtain the appropriate authorization can lead to consequences ranging ...Read More -
Government of Canada launches consultation on expanding the geographical indications regime
On May 28, 2026, the Government of Canada launched a public consultation on the scope of the geographical indications (GIs) regime under the Trademarks Act. The consultation seeks stakeholders' views ...Read More
